It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: Novo Nordisk has terminated its partnership with Hims & Hers Health, Inc. due to concerns over unsafe practices related to counterfeit Wegovy® drugs, emphasizing the importance of patient safety. Additionally, Novo Nordisk A/S reported positive results from its phase 3 REDEFINE 1 trial, demonstrating the effectiveness of CagriSema for weight loss in adults with obesity or overweight.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!